Diagnostics and Tools May 2023
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Oncimmune Ltd was acquired by Freenome, Inc.
- Gyrus Capital S.A. announced its acquisition of LRE Medical GmbH
- Viva Biotech (Shanghai) Ltd. closed a $14.5MM Series A Financing, led by Jiangsu Shengze Investment Co.,Ltd., VVB Fund, Shenzhen Zhongjince Investment Co., Ltd., VVB Fund